Anjarium Biosciences, a biotech company focused on creating and delivering a new class of non-viral gene therapies, has appointed Stephen Yoo as CEO. Yoo brings experience in building early-stage life sciences…
Anjarium Biosciences, a biotech company focused on creating and delivering a new class of non-viral gene therapies, has appointed Stephen Yoo as CEO. Yoo brings experience in building early-stage life sciences…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


